HUN
NYSE · Chemicals
Huntsman Corp
$9.09
-0.03 (-0.33%)
Financial Highlights (FY 2026)
Revenue
5.45B
Net Income
-272,385,173
Gross Margin
13.2%
Profit Margin
-5.0%
Rev Growth
-10.9%
D/E Ratio
0.74
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 13.2% | 13.2% | 63.1% | 63.1% |
| Operating Margin | -2.3% | -2.1% | 14.1% | 13.4% |
| Profit Margin | -5.0% | -4.8% | 17.3% | 17.0% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 5.45B | 6.11B | 858.75M | 725.13M |
| Gross Profit | 720.03M | 807.75M | 541.78M | 457.48M |
| Operating Income | -125,910,018 | -127,124,765 | 121.33M | 97.38M |
| Net Income | -272,385,173 | -275,013,075 | 148.53M | 123.30M |
| Gross Margin | 13.2% | 13.2% | 63.1% | 63.1% |
| Operating Margin | -2.3% | -2.1% | 14.1% | 13.4% |
| Profit Margin | -5.0% | -4.8% | 17.3% | 17.0% |
| Rev Growth | -10.9% | -10.9% | +15.4% | -1.1% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 335.15M | 335.15M | 120.44M | 110.00M |
| Total Equity | 454.50M | 454.50M | 874.99M | 828.54M |
| D/E Ratio | 0.74 | 0.74 | 0.14 | 0.13 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 149.62M | 159.45M | 172.06M | 128.56M |
| Free Cash Flow | — | — | 77.68M | 53.87M |